Literature DB >> 16596572

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events.

Michael J Bradburn1, Jonathan J Deeks, Jesse A Berlin, A Russell Localio.   

Abstract

For rare outcomes, meta-analysis of randomized trials may be the only way to obtain reliable evidence of the effects of healthcare interventions. However, many methods of meta-analysis are based on large sample approximations, and may be unsuitable when events are rare. Through simulation, we evaluated the performance of 12 methods for pooling rare events, considering estimability, bias, coverage and statistical power. Simulations were based on data sets from three case studies with between five and 19 trials, using baseline event rates between 0.1 and 10 per cent and risk ratios of 1, 0.75, 0.5 and 0.2. We found that most of the commonly used meta-analytical methods were biased when data were sparse. The bias was greatest in inverse variance and DerSimonian and Laird odds ratio and risk difference methods, and the Mantel-Haenszel (MH) odds ratio method using a 0.5 zero-cell correction. Risk difference meta-analytical methods tended to show conservative confidence interval coverage and low statistical power at low event rates. At event rates below 1 per cent the Peto one-step odds ratio method was the least biased and most powerful method, and provided the best confidence interval coverage, provided there was no substantial imbalance between treatment and control group sizes within trials, and treatment effects were not exceptionally large. In other circumstances the MH OR without zero-cell corrections, logistic regression and the exact method performed similarly to each other, and were less biased than the Peto method.

Mesh:

Year:  2007        PMID: 16596572     DOI: 10.1002/sim.2528

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  255 in total

Review 1.  The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis.

Authors:  Sally Eyers; Mark Weatherall; Philippa Shirtcliffe; Kyle Perrin; Richard Beasley
Journal:  J R Soc Med       Date:  2010-10       Impact factor: 5.344

2.  Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.

Authors:  Colin John Crooks; David Prieto-Merino; Stephen J W Evans
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

Review 3.  Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Authors:  Lisa Rambout; Laura Hopkins; Brian Hutton; Dean Fergusson
Journal:  CMAJ       Date:  2007-08-01       Impact factor: 8.262

4.  Perspective: effect of rosiglitazone on cardiovascular outcomes.

Authors:  Steven E Nissen
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

Review 5.  SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Huilin Tang; Qi Dai; Weilong Shi; Suodi Zhai; Yiqing Song; Jiali Han
Journal:  Diabetologia       Date:  2017-07-19       Impact factor: 10.122

6.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

7.  Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.

Authors:  Richard M Turner; Chun S Kwok; Chen Chen-Turner; Chinedu A Maduakor; Sonal Singh; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

8.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

9.  Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.

Authors:  Rohit Loomba; Ayana K Rowley; Robert Wesley; Karen G Smith; T Jake Liang; Frank Pucino; Gyorgy Csako
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

Review 10.  Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.

Authors:  Diana M Sobieraj; William L Baker; Elaine Nguyen; Erin R Weeda; Craig I Coleman; C Michael White; Stephen C Lazarus; Kathryn V Blake; Jason E Lang
Journal:  JAMA       Date:  2018-04-10       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.